Background In March, 2016, the UK Government proposed a tiered levy on sugar-sweetened beverages (SSBs; high tax for drinks with >8 g of sugar per 100 mL, moderate tax for 5-8 g, and no tax for <5 g). We estimate the eff ect of possible industry responses to the levy on obesity, diabetes, and dental caries.
Introduction
In 2015, the UK Scientifi c Advisory Committee on Nutrition published a report 1 on the evidence for the association between consumption of carbohydrates and health. The report clarifi ed the role of sugar for development of dental caries and identifi ed sugarsweetened beverages (SSBs) as a specifi c risk factor for weight gain and type 2 diabetes, recommending that SSB consumption should be minimised. Both Public Health England 2 and the UK House of Parliament's Health Committee 3 subsequently advised a tax on SSBs and, in March, 2016, the budget statement 4 included proposals for a soft drinks industry levy.
Taxes on SSBs have been previously introduced in Mexico, France, Hungary, and elsewhere; 5 however, the UK would be the fi rst to introduce a three-tiered levy.
The levy is presented as an incentive for the industry to reformulate existing products to remove sugar, reduce portion sizes, and promote new or existing low-sugar alternatives. The levy is due to be introduced in 2018, subject to parliament passing the legislation in 2017, with revenue hypothecated for an increase of physical activity and breakfast clubs in schools. 4 Although the UK Government has expressed a desire that the levy is not passed on to purchasers through price rises, this request cannot be mandated and the industry response is unknown. Other outcomes could include reformulation to reduce sugar content or changes in marketing to encourage purchasers to switch to low-sugar products or small portion sizes. Diff erent responses will have diff erent eff ects on consumption patterns for soft drinks and hence determine the health eff ects of the levy. 6 The aim of this study is to appraise the health eff ect of various discrete industry responses so that legislation for the soft drinks levy can be designed to maximise health gain.
Methods

Scenarios
We developed a comparative risk assessment model to estimate the eff ects of SSB reformulation, price changes, and changes to SSB market share on obesity, dental caries, and type 2 diabetes in the UK (fi gure). The baseline for the model was the 2014 UK population and we took all data for the model from the closest year for which data were freely available (appendix). We identifi ed and modelled three possible industry responses. First, reformulation to reduce sugar concentration; second, a rise in price; and third, activities to change the relative market share of high-sugar, mid-sugar, and low-sugar drinks. For each of these responses, the magnitude of the response is uncertain. Informed by evidence where available and expert opinion, for each response we identifi ed better-case and worse-case scenarios for reduction of sugar consumption, resulting in six scenarios (table 1) .
We adopt the government defi nitions of high-sugar drinks as those with more than 8 g of sugar per 100 mL, mid-sugar drinks as those with 5-8 g of sugar per 100 mL, and low-sugar drinks as those with less than 5 g of sugar per 100 mL. Soft drinks are defi ned as all drinks with added sugar or sweetener; SSBs are drinks with added sugar, excluding milk-based drinks, tea, and coff ee; concentrated SSBs are defi ned as SSBs that are intended to be diluted with water, and regular SSBs are intended to be drunk as sold.
Small producers will be excluded from the levy. 4 We searched all soft drinks sold through the Tesco website and extracted the names of manufacturers. We used the Companies House website to identify manufacturers fulfi lling the UK Government defi nition of a small company 9 and identifi ed 13 small companies, which together contributed 0·6% of total UK SSB sales. Therefore, we did not adjust our analyses to account for these companies.
The better-case reformulation scenario (scenario 1) assumed that industry would reduce the sugar concentration of high-sugar drinks by 30% and mid-sugar drinks by 15%. This assumption is based on the reformulation of Sprite and Lipton Ice Tea, which have both reduced their sugar concentration by 30% since 2013. 10, 11 In the worse-case scenario (scenario 2), we assumed a 5% reduction in sugar concentration of both high-sugar and mid-sugar drinks. This assumption was based on Coca-Cola's pledge made to the Public Health Responsibility Deal of a 5% reduction in calories across their sparkling drink range between 2012 and 2014; they achieved a 5·3% reduction. 11 Under both these scenarios, the volume consumed is assumed to remain constant.
To derive the price change scenarios, we used estimates from the Offi ce for Budget Responsibility that the levy will be 18 pence per L on mid-sugar drinks and 24 pence per L on high-sugar drinks.
12 Low-sugar drinks will not be taxed. Previous sugary drink taxes have been passed on at rates of between 50% and 100%, [13] [14] [15] and if the tax was entirely passed through to consumers, high-sugar concentrated drinks would, on average, increase in price by 75% and high-sugar regular drinks would increase by 31% (table 2) . Such price rises are markedly greater than in other examples of SSB taxes (most countries have adopted
Research in context
Evidence before this study The UK Government announced a soft drinks industry levy in March, 2016. Multiple observational and modelling studies have analysed the eff ect of soft drink taxes in other international settings; however, the UK would be fi rst to introduce a tiered industry levy (high tax for drinks with >8 g of sugar per 100 mL, moderate tax for 5-8 g, and no tax for <5 g) rather than a sales tax, as has been applied elsewhere. To our knowledge, no analyses of its potential impact have been done and no international precedent exists from which to predict the potential response of soft drink manufacturers to the levy.
Added value of this study
This study, to our knowledge, is the fi rst to estimate the health impact of the UK soft drinks industry levy. It focuses on obesity, diabetes, and oral health, for which evidence of a causal link between soft drink consumption and health is strongest. Previous evidence has suggested that soft drink taxes lead to price rises and subsequent reductions in purchases of targeted drinks. This study goes further and estimates the eff ects of six scenarios to illustrate the relative health impacts of three possible industry responses to the levy: reformulation, price rises, and changes to product market share.
Implications of all the available evidence
Each of the three responses modelled could lead to important health gains, with industry likely to react to the levy using a combination of all three. This study extends previous analyses of the eff ect of soft drink taxes to show the benefi ts of reformulation stimulated by the tiered levy. Our analyses show that substantial health benefi ts could occur if the levy stimulates reformulation. Further important health benefi ts from price changes will be mitigated if industry spread the price increase across their entire portfolio. Increases in market share for mid-sugar and low-sugar drinks could have substantial health benefi ts, but only if the market share comes at the expense of high-sugar drinks rather than people shifting from low-sugar to mid-sugar drinks. smaller tax rates and therefore, despite high pass-on rates, only result in a 5-15% price rise) 17 and are larger than the 20% often cited as being necessary to aff ect substantial behavioural change and improve health. 18 We therefore assumed that 50% of the price increase would be passed on to purchasers and that companies would not increase prices by more than 20% (table 2). The better case for price change (scenario 3) assumed that the tax is passed on only through SSBs. However, major soft drink manufacturers produce various beverages. Therefore, in a worse case for price change (scenario 4), we assume that the levy is passed on evenly across all soft drinks (both diet beverages and SSBs), fruit juice, and bottled water, resulting in a 6% price rise. We modelled passing on 100% of the price increase to consumers as a sensitivity analysis. As stated by the UK Government, we applied tax rates to concentrated drinks given their price per litre as drunk, assuming a ratio of concentrate to water of one to four, as used by the British Soft Drinks Association (BSDA). 10, 19 The appendix gives details of how we modelled the price change.
A change in SSB market shares might result from changes in product marketing, changing product size, or the introduction of new mid-sugar and low-sugar products. For example, the BSDA reports a 70% increase in expenditure on advertising of low-calorie or zero-calorie brands and growth in the sales of small pack sizes, 10 and new mid-sugar products have emerged, such as Coca-Cola Life, which has 30% less sugar than does full-sugar Coca-Cola. 20 Few data exist to inform the extent to which these activities drive changes in purchasing behaviour. However, the soft drinks industry has pledged to reduce energy intake from soft drinks by 20% from 2015 levels by 2020. 10 To achieve this target, we calculate that the market share of high-sugar drinks would need to fall by 12% alongside a 6% increase for each of mid-sugar and low-sugar drinks, as shown in scenario 5, our better case for sugar reduction. The worse case (scenario 6) acknowledges that increased marketing of new mid-sugar drinks might lead consumers to switch to this category from low-sugar drinks. We assume that mid-sugar drinks double their market share alongside equal reductions in the market share of high-sugar and low-sugar drinks.
Health impact modelling
We developed a comparative risk assessment model to estimate the eff ect of the changes to SSB purchasing on incidence of dental caries and type 2 diabetes and prevalence of obesity. Comparative risk assessment modelling requires identifi cation of risk factor-disease pairs. In this case, the risk factor is SSB consumption and the diseases are dental caries, type 2 diabetes, and obesity. A two-step process then estimates the impact of the risk factor on the diseases. First, changes in the risk factor between baseline (current behaviour) and scenarios are estimated. Second, changes in the diseases as a result of changes in the risk factor are calculated using population impact fractions and applied to baseline levels of disease in the population. Such methods are common to the fi eld of comparative risk assessment modelling 21 and are based on model parameters representing baseline risk factor and disease status and the epidemiological relations between risk factors and diseases, which are assumed to be causal. Change in price of drinks 7, 8 Change in equivalised SSB consumption
Change in bodyweight
Change in obesity prevalence
Change in diabetes incidence
Change in DMFT Change to SSB market share Scenario 5: breakdown in sales of soft drinks shifts from 58% to 64% for low-sugar drinks, 6% to 12% for mid-sugar drinks, and 36% to 24% for high-sugar drinks Scenario 6: breakdown in sales of soft drinks shifts to 55% for low-sugar drinks, 12% for mid-sugar drinks, and 33% for high-sugar drinks Low-sugar drinks is less than 5 g of sugar per 100 mL, medium-sugar drinks is 5-8 g of sugar per 100 mL, and high-sugar drinks is more than 8 g of sugar per 100 mL. SSB=sugar-sweetened beverage. *Including low-sugar or zero-sugar drinks, bottled water, fruit juice, and sweetened milk drinks, and not including tea, coff ee, unsweetened milk, and alcohol. 16 and change in price for the taxed drinks categories with diff erent rates of tax pass-throughs and as modelled in scenario 3 We sought parameters describing the direct relation between SSB consumption and health outcomes where possible from meta-analyses of randomised controlled trials where available or cohort studies (table 3) . [22] [23] [24] [25] [26] [27] [28] We modelled the relation between SSB consumption and diabetes and bodyweight as a function of SSB consumption. The reformulation scenarios (scenarios 1 and 2) assumed that SSB consumption stays constant, but the amount of sugar in the drinks reduces. To estimate the eff ect of these scenarios on obesity and diabetes, we derived estimates of equivalised SSB consumption, which rises and falls in direct proportion to volume of SSB consumed and average SSB sugar concentration. We standardised against the average sugar concentrations in drinks in the baseline scenario. For example, in the baseline scenario, the average sugar concentration of SSBs was 9·2 g per 100 mL and the average consumption was 213 mL per day. A reduction in the average sugar concentration to 8·2 g per 100 mL at the same level of consumption would have an equivalised SSB consumption of 190 mL per day. This equivalised SSB consumption arises because a reduction in consumption of SSBs from 213 mL per day to 190 mL per day at constant sugar concentrations would result in the same reduction of sugar as a reduction of sugar concentration from 9·2 g per 100 mL to 8·2 g per 100 mL at the same level of consumption. We used equivalised SSB con sumption as an input for diabetes and obesity modelling in all scenarios.
Uncertainty intervals refl ect the uncertainty in baseline sugar drink sales and consumption, disease burden, sensitivity to price changes, and associations between sugar or sugary drink consumption and health outcomes. We estimated them using 5000 iterations of a Monte Carlo analysis, with model parameters drawn from the published or estimated uncertainty of each parameter (appendix).
We applied all results to the 2014 UK population 29 and made separate estimates for each outcome by sex and age group using age-specifi c and sex-specifi c estimates of baseline SSB consumption and disease burden. Further details of the health impact model are in the appendix, including a sensitivity analysis in which the direct eff ect on weight of SSB consumption is replaced with an energy balance equation for comparison with other work that has used this method.
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Role of the funding source
There was no specifi c funding source for this study. The corresponding author had full access to all the data and had fi nal responsibility for the decision to submit for publication.
Results
The better case for reformulation (scenario 1) resulted in a fall in mean sugar content of SSBs equivalent to a reduction of 58·5 mL (95% uncertainty interval [95% UI 54·5-62·6; 10 kcal [9] [10] scenarios modelled. All simulated scenarios led to a fall in equivalised SSB consumption except for the worse case for market share, which resulted in a small increase. The largest falls for both sexes were among 11-18-year-olds who consume the largest volume of SSBs. The reduction in obesity prevalence resulting from each scenario is estimated to be greatest after scenario 1 (better case for reformulation; table 5), leading to an estimated reduction of 144 383 (95% UI 5102-306 743) of 15 470 813 individuals with obesity, 0·9% of the obese population. This fi gure is compared with the better cases for price change (scenario 3), which reduces the obese population by 81 594 (3588-182 669; 0·5%), and with change in market share (scenario 5), which reduces the obese population by 91 042 (4289-204 903; 0·6%). Results varied by age, with larger reductions in the number of children with obesity than in that of adults in scenario 1. The relative reduction in obesity prevalence was predicted to be greater in male individuals than in female individuals because male individuals consume a greater volume of SSBs (appendix). Eff ect size estimates were signifi cantly increased when an energy balance equation was used (appendix).
Across the scenarios modelled, the pattern of results seen with obesity is repeated for type 2 diabetes. Scenario 1 (better case for reformulation) resulted in an estimated 19 094 (95% UI 6920-32 678; incidence reduction of 31·1 per 100 000 person-years) fewer new cases of diabetes per year and scenario 6 (worse case for change in market share) led to an increase of 1238 (455-2359; incidence increase of 2·0 per 100 000 person-years) cases per year (table 6) . However, by contrast with the obesity results, adults aged older than 65 years saw the largest absolute reduction in diabetes incidence, refl ecting the positive association between age and disease burden.
All scenarios except for scenario 6 led to a fall in the numbers of teeth aff ected with dental caries (measured by the number of decayed, missing, or fi lled teeth [DMFT]; table 7). The better case for reformulation (scenario 1) had the largest eff ect size, reducing the annual incidence of DMFT by 269 375 (95% UI 82 211-470 928; incidence reduction of 4·4 per 1000 person-years). As with results for obesity and diabetes, the better case for change in market share (scenario 5) and price change (scenario 3) scenarios had the next largest eff ects respectively. Those aged 11-18 years were expected to have the greatest relative benefi t because of their higher baseline SSB consumption than those aged older or younger than this age group (appendix).
In our sensitivity analysis where 100% of the levy is passed on to consumers, equivalised SSB consumption would reduce by 71 mL (95% UI 66-77; 11 kcal [10] [11] [12] 
Discussion
The proposed UK soft drinks industry levy has the potential to reduce obesity prevalence, diabetes incidence, and dental caries incidence. The eff ect on health and the ranking of scenarios is sensitive to the manner in which industry responds to the levy and the uncertainty in the modelling. Our estimates suggest that the greatest benefi ts will result from reformulation, with less but still positive health eff ects after price changes and changes to SSB market share to increase the proportion of low-sugar drinks sold, although in the worse-case scenario for change in market share, the health eff ect was actually negative. Children will have the greatest relative health benefi t in terms of obesity and caries, with absolute reductions in diabetes incidence rates increasing with age.
Reformulation
Price change Change in market share The main strength of this study is the timely assessment of a planned government policy by simulating a set of discrete scenarios for how industry might respond to the levy to inform the detail of the legislation. Other strengths include modelling of multiple health outcomes, use of age-specifi c and sex-specifi c data, use of own-price and cross-price elasticities for high-sugar, mid-sugar, and low-sugar drinks, and use of equivalised SSB consumption to allow for changes in both sugar content and SSB volume.
Uncertainty intervals estimate the uncertainty arising from model parameters; however, the greatest uncertainty is how the soft drinks industry will respond to the levy. Given this uncertainty, our results should not be read as precise estimates of the impact of the levy, but instead should be used to compare the relative eff ects of diff erent scenarios. Moreover, industry is likely to respond with a blended approach that combines elements of reformulation, price changes, and marketing. Although the results have wide and overlapping uncertainty intervals, much of the uncertainty is correlated between scenarios. In all of the iterations of our Monte Carlo analysis, the best-case reformulation scenario was associated with the best health outcomes, which suggests that the ranking of scenarios is robust. We have not estimated uncertainty in how much of the levy is passed on to consumers (although a 100% pass-on is modelled as a sensitivity analysis) and we did not use child-specifi c estimates of the eff ect of SSB consumption on diabetes and dental caries incidence because of an absence of data available. We have assumed that disease risk from SSBs is dependent on the quantity of sugar consumed (more sugar leads to higher risk). Although fi ndings from studies 24 from a swap from SSBs to artifi cially sweetened beverages, we are not aware of any studies that have described the eff ect of a swap of SSBs with a high sugar content to SSBs with a low sugar content.
We have not modelled a temporal component. The eff ects on DMFT could occur soon after the change in SSB consumption, and the trials [22] [23] [24] [25] used to parameterise the relation between SSB consumption and weight suggest that falls in obesity would be expected within 6 months for adults and 12 months for children. The eff ects on type 2 diabetes could take longer to be realised than for obesity (median follow-up of observational studies 26 used for this parameter ranged between 3·4 years and 21·1 years). We have also not modelled results for diff erent subgroups. Individuals from diff erent socioeconomic backgrounds, ages, and baseline consumption levels could respond diff erently to each industry response simulated. Finally, we have not modelled the long-term health benefi ts of falls in obesity, the possible educational role the levy might have in highlighting that SSBs cause disease, 31 and the health eff ect of use of the revenue to improve school sport and nutrition.
This study is, to our knowledge, the fi rst to appraise the potential health eff ects of the UK soft drinks industry levy. The results of our study vary from those of a report by Oxford Economics, 32 which calculated the impact of a price change associated with a 100% pass-on of the levy to targeted products only, with no reformulation or market share (most similar to our scenario 3). The authors estimated that the levy would result in a 5 kcal per-person per-day fall in energy intake. Our sensitivity analysis of a 100% pass-on rate would result in a reduction of 11 kcal per person per day (before adjustment for BSDA sales fi gures). Two principal explanations exist for the diff erence. First, we estimate the average price before tax of dilutables as 22 pence per L, whereas Oxford Economics estimate it as £1·76 per L. This discrepancy is likely to be due to Oxford Economics applying the tax before dilution. Second, Oxford Economics used estimates of how consumers respond to price changes of diet and non-diet SSBs taken from our 2013 study estimating the eff ect on obesity of a 20% UK SSB tax. 30 In our present study, we have calculated estimates separately for high-sugar, mid-sugar, and low-sugar drinks.
Our 2013 study 30 estimated that a 20% price rise would lead to a 1·3% fall in the number of adults with obesity in the UK, compared with our scenario 3 estimate of 0·5% (after an average price rise of 15%). Our 2013 study did not estimate price elasticities separately for high-sugar and mid-sugar drinks, did not quantify the eff ect of the tax on children, and did not adjust for BSDA sales fi gures. It also used an energy balance equation rather than quantifying the direct eff ect of SSBs on bodyweight, which estimates larger eff ects on bodyweight than does quantifying the direct eff ect of SSBs on bodyweight. Conversely, in this study, we used an estimate of the direct relation between bodyweight and SSBs, which might more accurately represent substitution and other compensatory mechanisms secondary to changes in sugar (and energy) consumed from SSBs than use of an energy balance equation. This analysis substantiates our 2013 fi ndings of greater relative reductions in obesity among younger adults than among older adults. This fi nding is explained by teenagers and young adults drinking more SSBs than do old adults and trial data suggesting that SSBs have a greater eff ect on weight gain in children than in adults. [23] [24] [25] [26] Considering reformulation, Ma and colleagues 33 estimated that a 40% reduction in sugar across all SSBs in the UK would lead to 800 000 fewer individuals with obesity. This estimate is substantially higher than our estimate in scenario 1 (about 144 400), which assumed a 30% reduction in sugar content of high-sugar drinks and 15% reduction in that of mid-sugar drinks. This discrepancy is, in part, due to Ma and colleagues estimating that the average reduction in energy consumed would be approximately twice our estimate and then using an energy balance equation to estimate the eff ect of energy intake on weight. Of note, estimates for the reduction in diabetes were similar between our study and Ma and colleagues' study. We also recognise that uncertainties exist around all parameters in the model that will aff ect the comparison of results with those from other simulation studies.
The UK soft drinks industry levy has the potential to lead to important improvements in population health, particularly among children. Policy makers should engage with stakeholders to encourage responses to the levy that will maximise the potential health benefi ts of the new policy. Our results show the need for ongoing monitoring of the implementation strategies adopted by industry alongside modelling to estimate the long-term health consequences of their actions. Our results suggest that, of the scenarios modelled, reformulation would lead to the largest health benefi ts. Price rises and changes to product market share might also lead to important improvements in health. However, eff ects would be attenuated if manufacturers chose to pass the tax on to purchasers across all drinks or other products in their portfolio rather than just those targeted by the levy. Moreover, negative health eff ects might arise if the increase in market share of mid-sugar drinks comes at the expense of low-sugar drinks. Conversely, further health benefi ts might be realised if manufacturers pass on more than 50% of the levy to consumers or choose to reformulate to a greater extent than that modelled (as announced by Tesco 34 and Lucozade Ribena Suntory 35 ). The UK soft drinks industry levy could have valuable population health benefi ts, but the magnitude of its health impact will depend on how industry responds. The detail of the levy is yet to be decided, but we show important health benefi ts that could be maximised by substantial product reformulation, with further health gains arising through raising the price of high-sugar and mid-sugar drinks and increasing the market share of low-sugar products.
